天(tian)(tian)(tian)(tian)(tian)津(jin)天(tian)(tian)(tian)(tian)(tian)藥(yao)(yao)(yao)(yao)(yao)(yao)藥(yao)(yao)(yao)(yao)(yao)(yao)業(ye)(ye)股(gu)份有(you)(you)限(xian)公(gong)(gong)司(簡稱天(tian)(tian)(tian)(tian)(tian)藥(yao)(yao)(yao)(yao)(yao)(yao)股(gu)份)成立于1999年(nian)12月(yue)1日。 2001年(nian)6月(yue)18日在上海證券交易(yi)所(suo)上市,股(gu)票(piao)代碼600488。天(tian)(tian)(tian)(tian)(tian)藥(yao)(yao)(yao)(yao)(yao)(yao)股(gu)份的前身是天(tian)(tian)(tian)(tian)(tian)津(jin)制(zhi)藥(yao)(yao)(yao)(yao)(yao)(yao)廠,始建于1939年(nian)。自(zi)20世紀(ji)50-60年(nian)代,開發、研制(zhi)和(he)生產(chan)(chan)皮(pi)(pi)質(zhi)激素類原(yuan)料(liao)藥(yao)(yao)(yao)(yao)(yao)(yao),是中國皮(pi)(pi)質(zhi)激素類藥(yao)(yao)(yao)(yao)(yao)(yao)物的開拓者之(zhi)一(yi),國內頗具影響力的皮(pi)(pi)質(zhi)激素原(yuan)料(liao)藥(yao)(yao)(yao)(yao)(yao)(yao)科(ke)研、生產(chan)(chan)和(he)出口(kou)基(ji)地(di)。2017年(nian)公(gong)(gong)司完(wan)成了收(shou)購天(tian)(tian)(tian)(tian)(tian)津(jin)金(jin)耀藥(yao)(yao)(yao)(yao)(yao)(yao)業(ye)(ye)有(you)(you)限(xian)公(gong)(gong)司(簡稱“金(jin)耀藥(yao)(yao)(yao)(yao)(yao)(yao)業(ye)(ye)”)的重組項(xiang)目,實現了從(cong)單一(yi)“原(yuan)料(liao)藥(yao)(yao)(yao)(yao)(yao)(yao)”到“原(yuan)料(liao)藥(yao)(yao)(yao)(yao)(yao)(yao)和(he)制(zhi)劑(ji)(ji)”業(ye)(ye)務優勢互補(bu)、雙輪聯動(dong)的戰(zhan)略轉(zhuan)型(xing)。公(gong)(gong)司現有(you)(you)控股(gu)和(he)參(can)股(gu)公(gong)(gong)司16家,總資產(chan)(chan)43億(yi)元。天(tian)(tian)(tian)(tian)(tian)藥(yao)(yao)(yao)(yao)(yao)(yao)股(gu)份與金(jin)耀藥(yao)(yao)(yao)(yao)(yao)(yao)業(ye)(ye)均為高新技(ji)術企業(ye)(ye)。天(tian)(tian)(tian)(tian)(tian)藥(yao)(yao)(yao)(yao)(yao)(yao)股(gu)份主要生產(chan)(chan)皮(pi)(pi)質(zhi)激素及氨(an)基(ji)酸(suan)類原(yuan)料(liao)藥(yao)(yao)(yao)(yao)(yao)(yao),常年(nian)生產(chan)(chan)品(pin)種包括地(di)塞米松系列(lie)、潑尼松系列(lie)、甲潑尼龍系列(lie)、倍(bei)他(ta)米松系列(lie)等6大系列(lie)30余(yu)個(ge)皮(pi)(pi)質(zhi)激素原(yuan)料(liao)藥(yao)(yao)(yao)(yao)(yao)(yao)品(pin)種,年(nian)產(chan)(chan)能(neng)(neng)力250噸(dun)以上,氨(an)基(ji)酸(suan)原(yuan)料(liao)藥(yao)(yao)(yao)(yao)(yao)(yao)產(chan)(chan)能(neng)(neng)2000噸(dun)。金(jin)耀藥(yao)(yao)(yao)(yao)(yao)(yao)業(ye)(ye)擁有(you)(you)小容(rong)量(liang)注射劑(ji)(ji)、軟膏(gao)劑(ji)(ji)、乳(ru)膏(gao)劑(ji)(ji)、涂膜劑(ji)(ji)、凝(ning)膠劑(ji)(ji)、膜劑(ji)(ji)、栓劑(ji)(ji)、硬(ying)膠囊劑(ji)(ji)、丸劑(ji)(ji)、凍(dong)干(gan)粉針劑(ji)(ji)等14個(ge)劑(ji)(ji)型(xing)208個(ge)產(chan)(chan)品(pin)文號,其中片劑(ji)(ji)年(nian)產(chan)(chan)能(neng)(neng)力50億(yi)片以上,小容(rong)量(liang)注射劑(ji)(ji)、膏(gao)劑(ji)(ji)和(he)膠囊劑(ji)(ji)的年(nian)產(chan)(chan)能(neng)(neng)分別達52,400萬支(zhi)、30,000萬支(zhi)和(he)16,560萬粒。
天藥(yao)股份(fen)在(zai)天津、新(xin)加(jia)坡和(he)(he)美國(guo)新(xin)澤西建立了(le)三家(jia)控(kong)股銷(xiao)售(shou)公司,分別(bie)負責公司在(zai)歐(ou)洲、亞洲和(he)(he)美洲的(de)業務開拓(tuo),皮質激素原(yuan)料藥(yao)有(you)60%以上出口到(dao)亞洲、歐(ou)洲、美洲的(de)70多個(ge)國(guo)家(jia)和(he)(he)地(di)區,國(guo)內銷(xiao)售(shou)覆蓋中(zhong)國(guo)近百個(ge)城(cheng)市(shi),具有(you)較強(qiang)的(de)市(shi)場(chang)影響力和(he)(he)占有(you)率。金耀藥(yao)業的(de)制劑產品銷(xiao)售(shou)也(ye)是覆蓋全國(guo),產品品牌享譽國(guo)內外。收購(gou)金耀藥(yao)業后的(de)天藥(yao)股份(fen)將進一步整合(he)資(zi)源(yuan)、優化營銷(xiao)策略,強(qiang)化管理(li)和(he)(he)技術創新(xin),不斷夯(hang)實“激素專家(jia)”定位,實現(xian)企業的(de)健康持續發展。